Trial evaluates neuromodulation's potential role in ulcerative colitis, the most common form of IBD Boomerang Medical, Inc., a women-led bioelectronic medicine company, today announced a $20 million ...
Boomerang Medical, Inc., a women-led bioelectronic medicine company, today announced a $20 million Series B financing co-led by Arboretum Ventures and Hatteras Venture Partners. Proceeds will advance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results